about
The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitorsParoxysmal nocturnal hemoglobinuria from bench to bedsideThe mouse Kell blood group gene (Kel): cDNA sequence, genomic organization, expression, and enzymatic functionCloning and structural characterization of ECTACC, a new member of the transforming acidic coiled coil (TACC) gene family: cDNA sequence and expression analysis in human microvascular endothelial cells.PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features.Complement blockade with a C1 esterase inhibitor in paroxysmal nocturnal hemoglobinuriaGallbladder carcinosarcoma.Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemiaThe small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cellsSpontaneously arising red cells with a McLeod-like phenotype in normal donors.Primary myelofibrosis and its targeted therapy.Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.Onset of expression of the components of the Kell blood group complex.PD-1 pathway and its clinical application: A 20year journey after discovery of the complete human PD-1 gene.Mantle cell lymphoma and its management: where are we now?Paraneoplastic cerebellar degeneration as an early sign of classical Hodgkin lymphomaSuccessful discontinuation of eculizumab therapy in a patient with aHUSAssessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK inhibition as an Effective StrategyOccurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patient
P50
Q24318487-8D8841A3-D923-4A94-9F0A-6D2B8401EE26Q24599629-E601E65F-A640-4A52-8502-7BB26C3587C0Q28593268-EA0A0FAD-9AEB-4690-AA27-FEC0424F0446Q30168499-F6699766-9C95-4C29-97F3-D6F39B6D75EFQ33728184-87CF6060-0478-4C79-8861-29CE019B0EDFQ34603645-899B0A69-DB29-4729-A7E7-5D9F72D02DF9Q34815442-5FA3E322-53D2-4D69-8363-EB94852D2CC9Q35061800-271621F0-734C-4DB3-A44C-183E3C3C4827Q36133037-B389DB01-10CD-48F3-AA68-C88E19A8970FQ37479073-9BF1A17A-9924-45E4-BF27-975466DD28CEQ38931426-1E15F20C-CB37-4096-A34E-33A23D539E33Q39416260-C59427E3-CC5E-46A1-AE4E-F555E335459EQ46526707-8D6F835E-03B3-4956-828F-801CFF0CA444Q47739403-20E3ED1B-7B63-4BB7-8F89-F059AAD8A743Q61805953-52508B8B-3A88-4BBB-B745-89CD1FED4577Q86636382-52A632E2-B685-484F-A161-AEAEEC63E4B3Q86965447-28BB3EFD-3B35-4063-8BC5-4B6DD6218B59Q90538040-7E5A3153-5265-4833-B523-2B07EFEA2402Q92688564-63A53951-DD46-46D9-AC45-F5A69A349184
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jeffrey Pu
@ast
Jeffrey Pu
@en
Jeffrey Pu
@es
Jeffrey Pu
@nl
Jeffrey Pu
@sl
type
label
Jeffrey Pu
@ast
Jeffrey Pu
@en
Jeffrey Pu
@es
Jeffrey Pu
@nl
Jeffrey Pu
@sl
prefLabel
Jeffrey Pu
@ast
Jeffrey Pu
@en
Jeffrey Pu
@es
Jeffrey Pu
@nl
Jeffrey Pu
@sl
P106
P1153
7102908915
P21
P31
P496
0000-0001-7498-3159